Search

everythinglearnresearchcommunity

for

Search:↓

Hair microscopy is useful for diagnosing hair disorders, but clear definitions are needed for accurate genetic analysis.

The author clarified that Alopecia Areata Incognita (AAI) and diffuse Alopecia Areata (AA) are different conditions and the case discussed was actually AA, not AAI.

hHbl gene is active in hair shaft cells and some pilomatricomas.

Low-dose naltrexone might be a cheap and effective additional treatment for hair loss with scalp discomfort due to its anti-inflammatory effects and few side effects.

Monilethrix has no effective treatment, but avoiding hair trauma helps manage it.

Some people who got COVID-19 experienced temporary hair loss starting around 10 weeks after infection, with many seeing improvement within about 25 days.

Some hair protein genes evolved early and were adapted for use in hair follicles.

The author clarifies that alopecia areata incognito and diffuse alopecia areata are different types of hair loss with unique symptoms and challenges in diagnosis.

Stopping forehead irritation and using hydrocortisone helped a man's skin, Martinique has lower melanoma rates, a man had an allergy to a specific antifungal, another had unexplained cysts, certain drugs can cause skin reactions without always being interrelated, a link between Fanconi anemia and a skin condition was suggested, high levels of a certain protein may play a role in a type of psoriasis, and there's a need to study the connection between scalp pain and hair loss.

The treatment with an oral drug and topical lotion is effective and well-tolerated for hair loss after COVID-19.

Many people with hair loss, especially those with telogen effluvium and alopecia areata, often have a sensitive scalp.

A woman on immunosuppressants developed two rare scalp conditions, which improved with specific treatments.

The 675-nm diode laser may safely help treat telogen effluvium.

Diffuse lichen planopilaris greatly reduces quality of life.

Lichen planus on the scalp can cause scarring hair loss and has four main types.

Trichodynia is a challenging scalp condition to treat, needing gentle care and more research for better solutions.

Telogen effluvium is common after symptomatic COVID-19, especially in young females, and may be linked to nutritional deficiencies.

The tonic boosts hair growth and fights dandruff using natural electric energy.

"Burning scalp" syndrome causes discomfort and may be managed with special cosmetics.

Telogen effluvium is a common hair loss condition that can be managed with proper treatment and addressing underlying issues.

The young woman has a benign, hereditary skin condition with no signs of a more serious syndrome.

Some patients with hair loss after mild COVID-19 had positive tests for certain autoantibodies.

COVID-19 patients often experience temporary hair loss and scalp pain.

Telogen effluvium is a common, distressing condition causing excessive hair shedding and has significant psychological effects on patients.

Chemotherapy causes temporary hair loss in women, while Tamoxifen does not significantly affect hair, and genetics show no link between female pattern hair loss and common baldness genes.

Different skin conditions show distinct types of vessel inflammation, a new quality of life index for vulval disease is reliable, a certain intrauterine system might be linked to chronic vaginal yeast infections, and oral minoxidil reduces hair loss in women.

Most Iraqi women with telogen effluvium did not have a clear cause for their hair loss, and few had significant thinning.

Most Iraqi women with telogen effluvium had no clear cause for their hair loss, and few had significant thinning.

The study found that Temporal Triangular Alopecia often starts in early childhood, while Folliculitis Decalvans is characterized by tufted hairs and redness around hair follicles.

Hand-foot-mouth disease may cause nail loss in children.